Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Checkmate Pharmaceuticals, Inc. | d128572dex312.htm |
| EX-31.1 - EX-31.1 - Checkmate Pharmaceuticals, Inc. | d128572dex311.htm |
| 10-Q - 10-Q - Checkmate Pharmaceuticals, Inc. | d128572d10q.htm |
Exhibit 32.1
Certification Of
Principal Executive Officer
Pursuant To 18 U.S.C. Section 1350,
As Adopted Pursuant To
Section 906 of The Sarbanes-Oxley Act Of 2002
In connection with the Quarterly Report on Form 10-Q of Checkmate Pharmaceuticals, Inc. (the “Company”) for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
| 1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2) | The information contained in the Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Report and results of operations of the Company for the period covered by the Report. |
| Date: May 13, 2021 | /s/ Barry Labinger | |||
| Barry Labinger | ||||
| President and Chief Executive Officer | ||||
| (Principal Executive Officer) | ||||
| /s/ Robert Dolski | ||||
| Robert Dolski | ||||
| Chief Financial Officer | ||||
| (Principal Financial Officer) | ||||